PTOTSLPOtherDevelopmental medicine and child neurology2024

Pharmacological and neurosurgical management of cerebral palsy and dystonia: Clinical practice guideline update.

Darcy Fehlings, Brenda Agnew, Hortensia Gimeno and 8 others

PMID 38640091

WHAT IT FOUND

For dystonia in cerebral palsy, the guideline suggests considering oral/enteral baclofen, clonidine, gabapentin, botulinum toxin, intrathecal baclofen, or deep brain stimulation only after discussing benefits and harms with the family; it suggests against routine trihexyphenidyl and benzodiazepines, and against levodopa or medical cannabis.

Key findings

01All management suggestions in this guideline are conditional, so the choice depends on the person's goals and how they weigh benefits against side effects.

02It suggests baclofen, clonidine, gabapentin, botulinum toxin A, intrathecal baclofen, or deep brain stimulation for specific dystonia patterns; it suggests against routine trihexyphenidyl or benzodiazepines, and against levodopa or medical cannabis.

03These treatments are meant to be used alongside rehabilitation and other therapies, so the contribution of any single medication or procedure cannot be separated.

STILL TO COME

How it was doneWhat they foundWhat it means for PTsWhat it means for OTsWhat it means for SLPs

Read the rest of this summary

You get three full summaries a month, free, and we do not ask for a card. Search, the TL;DRs and your library stay unlimited either way.

Already have one?

What it does not show

This is a guideline, not a study of a treatment effect. Most recommendations are based on very low certainty evidence, often from populations other than cerebral palsy and dystonia. Many studies did not separate dystonia-related stiffness from other involuntary movements, so it is unclear which symptom a treatment improved. The evidence search stopped before more recent studies were considered, and access, cost, and surgical complexity may limit use of intrathecal baclofen and deep brain stimulation.

Declared interests

The guideline was funded by the American Academy for Cerebral Palsy and Developmental Medicine and the Ontario Brain Institute. No author conflicts of interest are stated in the supplied text.

The easy way to misread this

Do not read these suggestions as proof that any medication or surgery works for dystonia in cerebral palsy. Most recommendations are conditional and based on very low to low certainty evidence.

Read it on PubMed →